Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The challenge of drug resistance in cancer treatment: a current overview
Michail Nikolaou, Athanasia Pavlopoulou, Alexandros G. Georgakilas, et al.
Clinical & Experimental Metastasis (2018) Vol. 35, Iss. 4, pp. 309-318
Closed Access | Times Cited: 488

Showing 26-50 of 488 citing articles:

Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance
Nir Shahar, Sarit Larisch
Drug Resistance Updates (2020) Vol. 52, pp. 100712-100712
Closed Access | Times Cited: 125
New insights into small‐cell lung cancer development and therapy
Yuwen Wang, Songyun Zou, Zhuyun Zhao, et al.
Cell Biology International (2020) Vol. 44, Iss. 8, pp. 1564-1576
Open Access | Times Cited: 108
Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
The EPMA Journal (2021) Vol. 12, Iss. 2, pp. 155-176
Open Access | Times Cited: 101
Nanotechnology approaches in the current therapy of skin cancer
Lívia Neves Borgheti-Cardoso, Juliana Santos Rosa Viegas, Ana Vitória Pupo Silvestrini, et al.
Advanced Drug Delivery Reviews (2020) Vol. 153, pp. 109-136
Open Access | Times Cited: 100
Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance
Patrick Santos, Fausto Almeida
Cells (2020) Vol. 9, Iss. 6, pp. 1450-1450
Open Access | Times Cited: 94
Seaweed Secondary Metabolites In Vitro and In Vivo Anticancer Activity
Djenisa H. A. Rocha, Ana M. L. Seca, Diana C. G. A. Pinto
Marine Drugs (2018) Vol. 16, Iss. 11, pp. 410-410
Open Access | Times Cited: 92
Cancer recurrence and lethality are enabled by enhanced survival and reversible cell cycle arrest of polyaneuploid cells
Kenneth J. Pienta, Emma U. Hammarlund, Joel S. Brown, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 7
Open Access | Times Cited: 92
The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
Elena Andreucci, Jessica Ruzzolini, Silvia Peppicelli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2018) Vol. 34, Iss. 1, pp. 117-123
Open Access | Times Cited: 90
Multifunctional two-dimensional nanocomposites for photothermal-based combined cancer therapy
Xianwen Wang, Liang Cheng
Nanoscale (2019) Vol. 11, Iss. 34, pp. 15685-15708
Closed Access | Times Cited: 89
Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer
Cally J. Ho, Sharon M. Gorski
Cancers (2019) Vol. 11, Iss. 11, pp. 1775-1775
Open Access | Times Cited: 83
Role of aldo‐keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential
Reza Khayami, Seyyed Reza Hashemi, Mohammad Amin Kerachian
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 16, pp. 8890-8902
Open Access | Times Cited: 79
Nanoenabled Intracellular Calcium Bursting for Safe and Efficient Reversal of Drug Resistance in Tumor Cells
Junjie Liu, Chunyu Zhu, Lihua Xu, et al.
Nano Letters (2020) Vol. 20, Iss. 11, pp. 8102-8111
Closed Access | Times Cited: 79
ESCRT-III-mediated membrane repair in cell death and tumor resistance
Jiao Liu, Rui Kang, Daolin Tang
Cancer Gene Therapy (2020) Vol. 28, Iss. 1-2, pp. 1-4
Open Access | Times Cited: 77
Potential roles and prognostic significance of exosomes in cancer drug resistance
Mostafa Mostafazadeh, Nasser Samadi, Houman Kahroba, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 70
CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and Research
Fahreddin Palaz, Ali Kerem Kalkan, Özgür Can, et al.
ACS Synthetic Biology (2021) Vol. 10, Iss. 6, pp. 1245-1267
Closed Access | Times Cited: 62
Tumor-Homing and Immune-Reprogramming Cellular Nanovesicles for Photoacoustic Imaging-Guided Phototriggered Precise Chemoimmunotherapy
Zhijin Fan, Yichao Wang, Lanqing Li, et al.
ACS Nano (2022) Vol. 16, Iss. 10, pp. 16177-16190
Closed Access | Times Cited: 60
Helicobacter pylori–induced RASAL2 Through Activation of Nuclear Factor-κB Promotes Gastric Tumorigenesis via β-catenin Signaling Axis
Long‐Long Cao, Shoumin Zhu, Heng Lu, et al.
Gastroenterology (2022) Vol. 162, Iss. 6, pp. 1716-1731.e17
Open Access | Times Cited: 59
Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies
Jun Cao, Mengdi Zhang, Bin Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 58
Dieckol: a brown algal phlorotannin with biological potential
Durairaj Karthick Rajan, Kannan Mohan, Shubing Zhang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 111988-111988
Open Access | Times Cited: 58
Heterochiral β-Peptide Polymers Combating Multidrug-Resistant Cancers Effectively without Inducing Drug Resistance
Ning Shao, Ling Yuan, Pengcheng Ma, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 16, pp. 7283-7294
Closed Access | Times Cited: 51
Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets
Kharimat Lora Alatise, Samantha Gardner, Angela Alexander-Bryant
Cancers (2022) Vol. 14, Iss. 24, pp. 6246-6246
Open Access | Times Cited: 51
TRIM46 activates AKT/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells
Jicheng Tantai, Xufeng Pan, Yong Chen, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 42
Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action
Mitra Behroozaghdam, Maryam Dehghani, Amirhossein Zabolian, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Closed Access | Times Cited: 40
Gel Formulations for Topical Treatment of Skin Cancer: A Review
Marta Slavkova, Borislav Tzankov, Teodora Popova, et al.
Gels (2023) Vol. 9, Iss. 5, pp. 352-352
Open Access | Times Cited: 36
Synergistic effects of flavonoids and paclitaxel in cancer treatment: a systematic review
Solmaz Asnaashari, Elham Amjad, Babak Sokouti
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 36

Scroll to top